Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tretinoin and Arsenic Trioxide in Newly Diagnosed APL
NCT01404949Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2011
- Primary completion
- Feb 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of arsenic trioxide in acute promyelocytic leukemia (APL), sponsored by Memorial Sloan Kettering Cancer Center. Started Jul 2011; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT01404949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404949.